Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Epizyme Inc (EPZM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 731,953
  • Shares Outstanding, K 79,130
  • Annual Sales, $ 10,000 K
  • Annual Income, $ -134,310 K
  • 36-Month Beta 1.65
  • Price/Sales 73.90
  • Price/Cash Flow N/A
  • Price/Book 3.16

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.61
  • Number of Estimates 8
  • High Estimate -0.53
  • Low Estimate -0.83
  • Prior Year -0.63
  • Growth Rate Est. (year over year) +3.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.88 +4.73%
on 10/05/18
11.76 -20.92%
on 09/24/18
-0.85 (-8.37%)
since 09/14/18
3-Month
8.61 +8.01%
on 08/02/18
14.25 -34.74%
on 07/26/18
-4.45 (-32.36%)
since 07/16/18
52-Week
8.61 +8.01%
on 08/02/18
21.40 -56.54%
on 03/13/18
-8.40 (-47.46%)
since 10/16/17

Most Recent Stories

More News
Epizyme Inc Falls 1.07% on Heavy Volume: Watch For Potential Rebound

Epizyme Inc (NASDAQ:EPZM) traded in a range yesterday that spanned from a low of $9.06 to a high of $9.46. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $9.16 on...

EPZM : 9.31 (+0.65%)
Shares of EPZM Down 35.2% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Epizyme Inc (NASDAQ:EPZM) on June 15th, 2018 at $15.43. In approximately 4 months, Epizyme Inc has returned 35.17% as of today's recent price of $10.00.

EPZM : 9.31 (+0.65%)
Epizyme Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter's Option to Purchase Additional Shares

Epizyme, Inc. (Nasdaq: EPZM), a clinical-stage company developing novel epigenetic therapies, today announced the closing of its underwritten public offering of 9,583,334 shares of...

EPZM : 9.31 (+0.65%)
Epizyme Announces Pricing of Public Offering of Common Stock

Epizyme, Inc. (Nasdaq:EPZM), a clinical-stage company developing novel epigenetic therapies, today announced the pricing of an underwritten public offering of 8,333,334 shares of its common...

EPZM : 9.31 (+0.65%)
Epizyme Announces Proposed Public Offering of Common Stock

Epizyme, Inc. (Nasdaq: EPZM), a clinical-stage company developing novel epigenetic therapies, today announced that it intends to offer and sell shares of its common stock in an underwritten...

EPZM : 9.31 (+0.65%)
FDA Lifts Clinical Hold on Epizyme's Lead Candidate's Study

The FDA lifts partial clinical hold on Epizyme's lead pipeline candidate, tazemetostat's study.

ANIK : 42.22 (+2.73%)
LGND : 210.66 (+5.29%)
REGN : 398.86 (+5.64%)
EPZM : 9.31 (+0.65%)
Epizyme Announces the U.S. Food and Drug Administration Lifts Partial Clinical Hold on Tazemetostat Clinical Program

Epizyme, Inc. (NASDAQ: EPZM), a clinical-stage company developing novel epigenetic therapies, today announced the U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold...

EPZM : 9.31 (+0.65%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (IRWD , EPZM , ABBV , CARA , CTMX )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

IRWD : 17.37 (+6.76%)
ABBV : 91.50 (+2.60%)
EPZM : 9.31 (+0.65%)
Downtrend Call Working As Epizyme Inc Stock Falls 34.8% (EPZM)

SmarTrend identified a Downtrend for Epizyme Inc (NASDAQ:EPZM) on June 15th, 2018 at $15.43. In approximately 3 months, Epizyme Inc has returned 34.85% as of today's recent price of $10.05.

EPZM : 9.31 (+0.65%)
Epizyme Inc Shares Down 26.4% Since SmarTrend's Sell Call (EPZM)

SmarTrend identified a Downtrend for Epizyme Inc (NASDAQ:EPZM) on June 15th, 2018 at $15.43. In approximately 2 months, Epizyme Inc has returned 26.42% as of today's recent price of $11.35.

EPZM : 9.31 (+0.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade EPZM with:

Business Summary

Epizyme, Inc. is a biopharmaceutical company. It engages in the discovery, development, planning, and commercialization of therapeutics for cancers. Epizyme, Inc. is headquartered in Cambridge, Massachusetts.

See More

Key Turning Points

2nd Resistance Point 9.66
1st Resistance Point 9.45
Last Price 9.31
1st Support Level 9.05
2nd Support Level 8.86

See More

52-Week High 21.40
Fibonacci 61.8% 16.51
Fibonacci 50% 15.00
Fibonacci 38.2% 13.50
Last Price 9.31
52-Week Low 8.61

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar